MGMT and glioblastoma: We evaluate the performance of this novel classification strategy for predicting temozolomide treatment efficacy in comparison to PyroSeq techniques.<h4>Results</h4>MGMTai reliably predicted <i>MGMT</i> methylation status in GBM patients with available PyroSeq data.